{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:15:41Z","timestamp":1793646941579,"version":"4.5.1"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2065,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2982.2009.01449.x","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T03:15:55Z","timestamp":1262661355000},"page":"618-e173","source":"Crossref","is-referenced-by-count":106,"title":["Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100\u2003mg t.i.d. is an optimal dosage"],"prefix":"10.1111","volume":"22","author":[{"given":"K.","family":"Matsueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1,5]]},"reference":[{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1572-0241.2003.07389.x","article-title":"Symptoms associated with inpaired gastric emptying of solids and liquids in functional dyspepsia","volume":"98","author":"Sarnelli","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/gast.2001.27180","article-title":"Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia","volume":"121","author":"Tack","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/gut.45.2008.ii37","article-title":"Functional gastroduodenal disorder","volume":"45","author":"Talley","year":"1999","journal-title":"Gut"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB5|cit5","first-page":"A375","article-title":"Comparison of functional dyspepsia patients with or without meal-related symptoms","volume":"126","author":"Tack","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/j.gastro.2004.01.006","article-title":"G-protein \u03b23 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia","volume":"126","author":"Holtmann","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1572-0241.2006.00481.x","article-title":"A study of candidate genotypes associated with dyspepsia in a U.S. Community","volume":"101","author":"Camilleri","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.gastro.2005.04.012","article-title":"Dyspepsia and irritable bowel syndrome after a salmonella gastroenteritis outbreak: one-year follow up cohort study","volume":"129","author":"Mearin","year":"2005","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2982.2009.01449.x-BIB9|cit9","first-page":"R351","article-title":"Z-338, a novel prokinetic agent, stimulatcs gastrointestinal motor activity and improves delayed gastric emptying in the dog and rat","volume":"358","author":"Ueki","year":"1998","journal-title":"Naunyn Schmiedbergs Arch Pharmacol"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2982.2009.01449.x-BIB10|cit10","first-page":"R356","article-title":"In vitro pharmacological profile of Z-338, a novel gastroprokinetic agent","volume":"358","author":"Kurimoto","year":"1998","journal-title":"Naunyn Schmiedbergs Arch Pharmacol"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2982.2009.01261.x","article-title":"A dose-ranging, placebo-controlled pilot trial of acotiamide in patients with functional dyspepsia","volume":"21","author":"Tack","year":"2001","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2982.2009.01449.x-BIB12|cit12","first-page":"A-467","article-title":"Therapeutic efficacy of novel agent (Z-338) in Functional Dyspepsia (FD)","volume":"128","author":"Matsueda","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB13|cit13","volume-title":"RomeII: The Functional Gastrointestinal Disorders","author":"Drossman","year":"2000"},{"issue":"Suppl. 231","key":"10.1111\/j.1365-2982.2009.01449.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/003655299750025237","article-title":"Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the domestic\/international gastroenterology surveillance study (DIGEST)","volume":"34","author":"Stanghellini","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2005.09.020","article-title":"American Gastroenterological Association technical review on the evaluation of dyspepsia","volume":"129","author":"Talley","year":"2005","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2982.2009.01449.x-BIB16|cit16","first-page":"154","article-title":"A phase II placebo controlled randomized trial with tegaserod in functional dyspepsia patients with normal gastoric emptying","volume":"122","author":"Tack","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB17|cit17","first-page":"1","article-title":"Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials","volume":"103","author":"Vakil","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJMoa052639","article-title":"A placebo-controlled trial of Itopride in functional dyspepsia","volume":"354","author":"Holtmann","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/gut.2007.132449","article-title":"Itopride in functional dyspepsia: results of two Phase III multicenter, randomized, double-blind, placebo-controlled trials","volume":"57","author":"Talley","year":"2008","journal-title":"Gut"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2982.2009.01449.x-BIB20|cit20","first-page":"A-506","article-title":"Initial approach and pharmacotherapy for functional dyspepsia - a large clinical trial in Japan","volume":"130","author":"Hongo","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1254\/jphs.FPJ04056X","article-title":"Effects of rikkunshi-to, a traditional Japanese medicine, on the delay of gastric emptying induced by N(G)-nitro-L-arginine","volume":"98","author":"Kido","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2036.2003.01709.x","article-title":"Consensus report: clinical trial guidelines for pharmacological treatment of irritable bowel syndrome","volume":"18","author":"Corazziari","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2036.2008.03629.x","article-title":"Clinical trial: phase 2 study of lubiprostone for irritable for irritable bowel syndrome with constipation","volume":"27","author":"Johanson","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1046\/j.1365-2036.2001.01094.x","article-title":"Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation","volume":"15","author":"M\u00fcller-Lissner","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1365-2982.2008.01135.x","article-title":"Acotiamide hydrochloride (Z-338), a novel prokinetic agent, restores delayed gastric emptying and feeding inhibition induced by restraint stress in rats","volume":"20","author":"Seto","year":"2008","journal-title":"Neurogastroenterol Motil"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of Omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the BOND and OPERA studies)","volume":"12","author":"Talley","year":"1998","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1053\/j.gastro.2004.08.026","article-title":"The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis","volume":"127","author":"Moayyedi","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2982.2009.01449.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2007.03.004","article-title":"Primary endpoints for FGID trials: a review of binary and integrated symptom assessments","volume":"5","author":"Camilleri","year":"2007","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2009.01449.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2982.2009.01449.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T11:47:38Z","timestamp":1625572058000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2009.01449.x"}},"subtitle":["Acotiamide in functional dyspepsia"],"short-title":[],"issued":{"date-parts":[[2010,1,5]]},"references-count":28,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2009.01449.x","relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,5]]}}}